NCT04140669View on ClinicalTrials.gov

Automated Myocardial Performance Index Using Samsung HERA W10

TerminatedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

July 7, 2020

Study Completion Date

July 7, 2020

Conditions
Twin to Twin Transfusion SyndromeCongenital Diaphragmatic HerniaNeural Tube DefectsLower Urinary Tract Infection
Interventions
DEVICE

Automated Myocardial Performance Index (MPI)

Automated Myocardial Performance Index will be performed using Samsung HERA W10 prior too fetal surgical interventions, during surgery, and following surgery.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04140669 - Automated Myocardial Performance Index Using Samsung HERA W10 | Biotech Hunter | Biotech Hunter